Clinic
LA Familia Health Clinic PLLC
LA Familia Health Clinic PLLC was paid $2.46M by Medicaid between Sep 2020 and Dec 2024, across 79 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 24% of everything it billed.
33Billing provider infoLA FAMILIA HEALTH CLINIC PLLC
LAREDO, TX 78040
LAREDO, TX 78040
33aNPI1962063917assigned 06/20/2019
33bProvider typeUrgent Care Clinic/Center
28Total paid$2.46M
24GClaims133,202
24DCodes billed79
24AFirst – last monthSep 2020 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Texas
Rank by total paid#14 of 151
Median peer was paid$125K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 765 | $23K | |
| 2021 | 8,714 | $218K | |
| 2022 | 25,653 | $595K | |
| 2023 | 60,448 | $876K | |
| 2024incomplete | 37,622 | $750K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 24% | 15,650 | 13,686 | $585K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 11,488 | 9,773 | $377K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 14% | 20,665 | 14,356 | $342K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 6,262 | 5,978 | $292K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 7.7% | 17,090 | 15,352 | $191K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 6.8% | 3,266 | 3,111 | $167K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6.0% | 9,280 | 7,808 | $148K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.0% | 1,628 | 1,583 | $124K |
| 86328 | 2.1% | 1,477 | 1,365 | $51K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,919 | 1,851 | $24K |
| 99000 | <1% | 2,242 | 2,015 | $21K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 152 | 124 | $20K |
67 more codes
| 99050 | <1% | 1,117 | $15K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 972 | $12K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,188 | $11K |
| 99384 | <1% | 141 | $10K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 137 | $8K |
| 0072A | <1% | 206 | $8K | |
| 0071A | <1% | 178 | $7K | |
| 87631 | <1% | 57 | $7K | |
| 87807 | <1% | 845 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,023 | $6K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 57 | $4K |
| 99382 | <1% | 47 | $4K | |
| 99383 | <1% | 44 | $4K | |
| 0001A | <1% | 67 | $3K | |
| 81003 | <1% | 1,655 | $3K | |
| 97169 | <1% | 64 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,574 | $2K |
| 0002A | <1% | 38 | $1K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 181 | $1K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 14 | $1K |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 250 | $846.67 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 50 | $705.84 |
| S9470 | Nutritional counseling, dietitian visit | <1% | 81 | $661.88 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 84 | $653.18 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 38 | $651.04 |
| 0064A | <1% | 16 | $640.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 53 | $594.72 |
| 0004A | <1% | 12 | $440.00 | |
| 94760 | <1% | 827 | $401.10 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 76 | $264.02 |
| 96160 | <1% | 167 | $243.99 | |
| 90461 | <1% | 64 | $60.46 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 607 | $14.84 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 215 | $0.39 |
| 90651 | <1% | 147 | $0.06 | |
| 90621 | <1% | 60 | $0.02 | |
| 90677 | <1% | 12 | $0.01 | |
| 99051 | 0% | 536 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 644 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 145 | $0.00 |
| 99173 | 0% | 309 | $0.00 | |
| 90658 | 0% | 12 | $0.00 | |
| 94664 | 0% | 941 | $0.00 | |
| 90715 | 0% | 122 | $0.00 | |
| 90633 | 0% | 76 | $0.00 | |
| 3078F | 0% | 3,641 | $0.00 | |
| 90710 | 0% | 119 | $0.00 | |
| 99072 | 0% | 27 | $0.00 | |
| 91300 | 0% | 169 | $0.00 | |
| 3077F | 0% | 12 | $0.00 | |
| 90700 | 0% | 12 | $0.00 | |
| 90733 | 0% | 185 | $0.00 | |
| 3037F | 0% | 4,439 | $0.00 | |
| 3074F | 0% | 3,851 | $0.00 | |
| 3079F | 0% | 347 | $0.00 | |
| 90696 | 0% | 83 | $0.00 | |
| 90686 | 0% | 59 | $0.00 | |
| 2001F | 0% | 4,484 | $0.00 | |
| 91306 | 0% | 16 | $0.00 | |
| 3008F | 0% | 4,275 | $0.00 | |
| 91307 | 0% | 367 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 72 | $0.00 |
| 2010F | 0% | 4,491 | $0.00 | |
| 96127 | 0% | 102 | $0.00 | |
| 3075F | 0% | 108 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 45 | $0.00 |
| 97802 | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRENDON, ROSA (NURSE PRACTITIONER/ADMINISTRATOR)